Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
61
CRDF Quote, Financials, Valuation and Earnings
Last price:
$4.46
Seasonality move
:
13.5%
Day range:
$4.39 - $4.55
52-week range:
$2.01 - $5.64
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
401.92x
P/B ratio:
4.18x
Volume:
1.4M
Avg. volume:
1.4M
1-year change:
75.2%
Market cap:
$296M
Revenue:
$683K
EPS (TTM):
-$0.92
Earnings Data
Next earnings date for CRDF
Aug 08
2025
Most recent earnings per share
-$0.20
Missed by $0.01
(May 8/2025)
Consensus Estimate
-$0.19
(May 8/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
CRDF Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $106.3K | -- | -- | -$0.20 | -- |
| 08/08/2025 | Q2 | $106.3K | -- | -- | -$0.20 | -- |
| 05/08/2025 | Q1 | $89.3K | $109K | -$0.20 | -$0.19 | -$0.01 |
| 02/27/2025 | Q4 | $94.2K | $151K | -$0.21 | -$0.25 | $0.04 |
| 11/07/2024 | Q3 | $70K | $165K | -$0.25 | -$0.27 | $0.02 |
| 08/08/2024 | Q2 | $58.8K | $163K | -$0.26 | -$0.25 | -$0.01 |
| 05/02/2024 | Q1 | $55K | $205K | -$0.22 | -$0.25 | $0.03 |
| 02/29/2024 | Q4 | $37.5K | $156K | -$0.21 | -$0.28 | $0.07 |
| 11/02/2023 | Q3 | -- | -- | -$0.22 | -$0.30 | $0.08 |
| 08/09/2023 | Q2 | -- | -- | -$0.25 | -$0.25 | $0.00 |
| 05/04/2023 | Q1 | -- | -- | -$0.25 | -$0.22 | -$0.03 |
| 03/02/2023 | Q4 | -- | -- | -$0.20 | -$0.25 | $0.05 |
| 11/03/2022 | Q3 | -- | -- | -$0.20 | -$0.24 | $0.04 |
| 08/04/2022 | Q2 | -- | -- | -$0.24 | -- | -- |
| 05/05/2022 | Q1 | -- | -- | -$0.25 | -- | -- |
| 02/24/2022 | Q4 | -- | -- | -$0.23 | -- | -- |
| 11/04/2021 | Q3 | -- | -- | -$0.17 | -- | -- |
| 08/05/2021 | Q2 | -- | -- | -$0.17 | -- | -- |
| 05/06/2021 | Q1 | -- | -- | -$0.14 | -- | -- |
| 02/25/2021 | Q4 | -- | -- | -$0.18 | -- | -- |
| 11/05/2020 | Q3 | -- | -- | -$0.19 | -- | -- |
| 08/11/2020 | Q2 | -- | -- | -$0.51 | -- | -- |
| 05/07/2020 | Q1 | -- | -- | -$0.41 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | -$0.51 | -- | -- |
| 09/30/2019 | Q3 | -- | -- | -$0.69 | -- | -- |
| 06/30/2019 | Q2 | -- | -- | -$0.76 | -- | -- |
| 03/31/2019 | Q1 | -- | -- | -$1.02 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | -$1.09 | -- | -- |
| 11/09/2018 | Q3 | -- | -- | -$1.10 | -- | -- |
| 06/30/2018 | Q2 | -- | -- | -$5.27 | -- | -- |
| 03/31/2018 | Q1 | -- | -- | -$6.23 | -- | -- |
| 02/26/2018 | Q4 | -- | -- | -$4.32 | -- | -- |
| 11/09/2017 | Q3 | -- | -- | -$8.46 | -- | -- |
| 08/09/2017 | Q2 | -- | -- | -$18.72 | -- | -- |
| 05/10/2017 | Q1 | -- | -- | -$23.04 | -- | -- |
| 03/15/2017 | Q4 | -- | -- | -$24.48 | -- | -- |
| 11/09/2016 | Q3 | -- | -- | -$24.48 | -- | -- |
| 08/04/2016 | Q2 | -- | -- | -$24.48 | -- | -- |
| 03/31/2016 | Q1 | -- | -- | -$25.92 | -- | -- |
| 12/31/2015 | Q4 | -- | -- | -$18.72 | -- | -- |
| 09/30/2015 | Q3 | -- | -- | -$16.56 | -- | -- |
Cardiff Oncology Earnings Questions
-
How Much did Cardiff Oncology Generate in Revenue Last Quarter?
Cardiff Oncology reported $109K worth of top line sales in its most recent quarter.
-
Did Cardiff Oncology Beat Earnings Last Quarter?
Cardiff Oncology announced earnings per share of -$0.20 which represents a miss of analyst forecast a -$0.19 per share.
-
Is Cardiff Oncology Profitable?
Cardiff Oncology reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Cardiff Oncology EPS Next Year?
Cardiff Oncology's earnings are forecast to decrease from -$0.95 per share to -$0.99 per share next year representing a decrease of -10.11%.
-
When is Cardiff Oncology's Earnings Date?
Cardiff Oncology's next earnings date is August 8, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
93
EXOD alert for Jul 18
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
